Eugene Marcantonio
Algemeen Directeur bij ARMGO Pharma, Inc.
Actieve functies van Eugene Marcantonio
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-10-2017 | - |
| Algemeen Directeur | 01-01-2021 | - | |
| Hoofd Techniek/Wetenschap/O&O | 01-04-2017 | 01-01-2021 | |
| President | 01-04-2017 | 01-01-2021 |
Loopbaan van Eugene Marcantonio
Opleiding van Eugene Marcantonio
| New York University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Beurs
- Insiders
- Eugene Marcantonio
- Ervaring
